Amụma nyocha ngwa ngwa ngwa ngwa nke Covid-19 antigen zuru ụwa ọnụ na 2021-2027 na-enye nyocha zuru oke nke mpaghara ahịa, gụnyere ike ya, ọnụ ọgụgụ ya, uto ya, ihe ndị achọrọ n'usoro iwu, mpaghara asọmpi na ohere na-apụta na ụlọ ọrụ ụwa.O mere nyocha miri emi nke ngwa ngwa ngwa ngwa ngwa nnwale Covid-19 site na iji nyocha SWOT.Onye nyocha nyocha kọwara oke uru na nyocha nkesa ya nke ọma.Nnyocha ahịa a na-enye data zuru oke nke nwere ike ime ka nghọta, oke na ntinye nke akụkọ a dịkwuo elu
Akuko a na-akwalite ikike ime mkpebi ma na-enyere aka ịmepụta usoro mgbochi dị irè iji nweta uru asọmpi.
Nweta nlere nṅomi nke akụkọ a dị elu: https://brandessenceresearch.com/requestSample/PostId/1542?utm_source=mmc&utm_medium=Djay
Ngwa ngwa nyocha ngwa ngwa Covid-19 Antigen bụ ngwa nyocha ngwa ngwa dabara adaba maka nchọpụta ozugbo ma nwee ike ịchọpụta ọnụnọ antigen n'ime ahụ onye ọrịa ngwa ngwa.Ọ nwere ike inye aka belata mgbasa ozi ọzọ site n'ịchọpụta ihe dị mma n'oge, si otú ahụ mee ka ịchọta kọntaktị dị ngwa ngwa.A na-emepụta ngwa ndị a site na ihe ndị na-eme nyocha ngwa ngwa in vitro na ụlọ ọrụ akụrụngwa ụlọ ọgwụ.Ngwa ngwa ngwa nnwale nke Covid-19 na-enye nsonaazụ n'ime awa ole na ole.Ndị otu metụtara imepụta ngwa ngwa ule ngwa ngwa a na-etinyekarị aka na nyocha, imewe na imepụta ngwa ngwa ule ngwa ngwa.Na mgbakwunye, enwere ọtụtụ uru metụtara ngwa ngwa nchọpụta antigen Covid-19, dị ka izi ezi, ọnụ ala dị ala, nsonaazụ ngwa ngwa, nchọpụta ọrịa mmalite, na nkwụsi ike dị elu.A na-eji ngwa nyocha ngwa ngwa Covid-19 antigen ugbu a na ọrịa COVID-19.Ọtụtụ ụlọ ọrụ teknụzụ dị mkpa na ụlọ ọrụ ọgwụ ewepụtala ngwa ngwa nchọpụta Covid-19 nke antigen nke ha, ọtụtụ ụlọ ọrụ ka na-atụnye ụtụ, na-eme nyocha ma na-arụ ọrụ iji melite ngwa ngwa nchọpụta ngwa ngwa ka mma.A na-eji ngwa nnwale antigen ngwa ngwa Covid-19 n'ụlọọgwụ na ebe a na-ahụ maka ihe mberede, ihe gbasara ezinụlọ, ụlọ nyocha nyocha, na ntọala nyocha.
Geographically, akụkọ ahụ kewara ụwa n'ime ọtụtụ isi mpaghara, yana ego ha nwetara (nde dollar) mpaghara (North America, Europe, Asia Pacific, Latin America, na Middle East na Africa) na-elekwasị anya na mba ndị bụ isi na mpaghara ọ bụla.Ọ na-ekpuchikwa ndị na-anya ụgbọ ala, ihe mgbochi, ohere, ihe ịma aka na isi okwu na ahịa ngwa ngwa ngwa ngwa ngwa ngwa ngwa ngwa nke Covid-19 zuru ụwa ọnụ.
Akuko Ahịa Ngwa Global Rapid Covid-19 Antigen Test Kit na-ekpuchi nyocha nke akụkọ ihe mere eme na amụma dị omimi.
Global Rapid Covid-19 Antigen Test Kit Market Report Report na-enye ozi zuru ezu na iwebata ahịa, nchịkọta ahịa, ego ha nwetara n'ahịa zuru ụwa ọnụ (ego ha nwetara dollar), ndị ọkwọ ụgbọ ala, mmachi ahịa, ohere ahịa, nyocha asọmpi, ọkwa mpaghara na obodo.
Akuko Ahịa Global Rapid Covid-19 Antigen Test Kit na-ekpuchi nyocha buru ibu nke usoro na-apụta na mpaghara asọmpi.
Ndị isi egwuregwu kpuchiri na mkpesa ngwa ngwa ngwa ngwa ngwa ngwa nke Covid-19 antigen zuru ụwa ọnụ gụnyere Abbott Rapid Diagnostics, Cipla, AMEDA Labordiagnostik GmbH, Becton Dickinson, Beijing Lepu Medical Technology, BIOSYNEX SWISS SA, CerTest Biotect SL, Hangzhou Clongene Biotech, Healgen Scientifico Limited , LumiraDX UK Ltd., nal von miden GmbH, Quidel Corporation, SD BIOSENSOR, Inc.;Roche, Siemens Medical, Xiamen Bosheng Biotechnology Co., Ltd., Zhejiang Oriental Gene Biotechnology Co., Ltd., wdg.
Akuko ngwa ngwa ngwa ngwa ngwa ngwa ngwa ngwa nke Covid-19 zuru ụwa ọnụ na-ekpuchi North America, Europe, Asia Pacific na mpaghara ndị ọzọ nke ụwa.Dabere na ọkwa mba, ahịa ngwa nnwale ngwa ngwa nke Covid-19 antigen na-ekewa n'ime United States, Mexico, Canada, United Kingdom, France, Germany, Italy, China, Japan, India, Ndịda Ebe Ọwụwa Anyanwụ Eshia, Middle East (UAE). ), Saudi Arabia, Egypt) Kọmitii Mmekọrịta Gulf, Africa, wdg.
Na Disemba 16, 2020;Cipla na Premier Medical Corporation Private Limited Association nke India weputara ngwa ngwa nchọpụta antigen maka nyocha Covid-19.Nnwale a bụ ihe nleba anya ngwa ngwa nasopharyngeal swab test nke nwere ike ịmata ọnụnọ nke Covid-19 antigen n'ime ahụ onye ọrịa wee mepụta nsonaazụ n'ime nkeji 15-20.A na-ere ule ahụ n'okpuru aha aha "CIPtest".Nke a bụ izipu nke abụọ nke Cipla na mpaghara nyocha mgbe ngwa ule Elifast ELISA gasịrị.Na nkwado a, Cipla ga-ahụ maka ire na nkesa ngwa ngwa nchọpụta antigen nke Premier Medical Corporation Private Limited mepụtara maka njirimara nke SARS-CoV-2 antigen.
Ọrịa na-atụghị anya ya na mgbasa nke ọrịa Covid-19, ịba ụba itinye ego na mmepe nke nnwale ngwa ngwa ka mma na nke dị elu, imekọ ihe ọnụ n'etiti gọọmentị na ndị otu nzuzo iji kwalite uto ahịa.
Otu n'ime isi ihe na-ebute uto ngwa ngwa nke ngwa ngwa nyocha nke Covid-19 zuru ụwa ọnụ bụ ntiwapụ na mgbasa nke nje Covid-19 zuru ụwa ọnụ na mberede.Dị ka data sitere na Healthtù Ahụ Ike (wa (WHO) si kwuo, ndị dị afọ 25-39 nwere ọnụ ọgụgụ kasị elu nke ndị a kọrọ akụkọ ha n'ụwa nile, na ihe dị ka 50% nke ikpe na-eme n'ime afọ 25-64.Na mgbakwunye, pasent nke ọnwụ na-abawanye na afọ, na n'afọ 2020, ihe dịka 75% nke ọnwụ ga-eme n'etiti ndị dị afọ 65 na karịa.Na mgbakwunye, itinye ego na-abawanye na mmepe nke ngwa nnwale ngwa ngwa Covid-19 dị elu akwalitela ngwa ngwa ngwa ngwa ngwa ngwa ngwa ngwa ngwa ngwa nke Covid-19 n'oge amụma amụma.Ọmụmaatụ;Foundation for Innovative Diagnostics (FIND) na Unitaid kwupụtara na mgbe oku ọha maka nkwupụta nke ebumnuche (EOI) bidoro na Julaị 4, 2020, emechaala batch mbụ nke nkwekọrịta iji kwalite ohere ezi uche dị na ịnweta antigens-nchọpụta nke Covid- 19 Nnwale nyocha ngwa ngwa (Ag RDT).Na mgbakwunye, njikọta nke gọọmentị na ndị otu nzuzo na ụbara ego gọọmentị akwalitewokwa uto nke ahịa ahụ.Ọmụmaatụ;na 2020, Pan American Health Organisation haziri 190,000 ọhụrụ COVID-19 antigen diagnostic test, nyere ha mba anọ na Latin America na Caribbean, ma nata ọzụzụ ka ha na-eduzi ule pilot na ọrụ ha.Na mgbakwunye, Pan American Health Organisation's Strategic Fund, usoro nkwado teknụzụ mpaghara na-elekwasị anya n'ịzụta ọgwụ dị mkpa na ngwaahịa ịdị ọcha, na-arụkọ ọrụ na mba dị iche iche iji kwalite ịnweta ule nyocha ndị a.Ọmụmaatụ;Gọọmentị Canada kwuputara onyinye izizi ya na ogidi ọgwụgwọ nke UNICEF, bụ nke malitere na nso nso a nweta ohere ịnweta ego enyemaka COVID-19 Tool Accelerator Supply Financing Facility ("ACT-A SFF") iji luso ọrịa a ọgụ.
Agbanyeghị, ngwa ngwa ngwa ngwa ngwa ngwa nke Covid-19 nwere ike ịchọ nnwale nkwenye n'ihi na ọ nwere ike inye nsonaazụ ule ụgha na obere uche ma e jiri ya tụnyere ule nucleic acid amplification test (NAAT), ọkachasị na ndị asymptomatic, nke nwere ike igbochi uto ahịa.Ka o sina dị, itinye ego na-abawanye ụba nke gọọmentị na ndị otu nzuzo gburugburu ụwa na mmepụta ngwa ngwa nchọpụta Covid-19 antigen nwere ike inyekwu ohere maka uto ahịa n'ihu.
Isi nke 1, gbasara nchịkọta ndị isi, na-akọwa nkọwa, nkọwapụta na nhazi, ngwa, na akụkụ ahịa nke ngwa ngwa ngwa ngwa nchọpụta Covid-19 zuru ụwa ọnụ.
Isi nke 4 na 5 na-egosi nyocha ahịa, nkewa na njirimara nke ngwa ngwa nchọpụta antigen Covid-19;
Isi nke 6 na 7, na-egosi ike ise (ikike ịzụ ahịa / onye na-azụ ahịa), ihe egwu nye ndị batara ọhụrụ na ọnọdụ ahịa;
Isi nke 8 na 9, na-egosi nyocha nke mpaghara gbajiri [North America (nke kpuchiri n'Isi nke 6 na Isi nke 13), United States, Canada, Mexico, Europe (kpuchie n'Isi nke 7 na Isi nke 13), Germany, United Kingdom, France, Italy , Spain, Russia, mpaghara ndị ọzọ, Asia Pacific (gụnyere na isi nke 8 na 13), China, Japan, South Korea, Australia, India, Ndịda Ebe Ọwụwa Anyanwụ Eshia, mpaghara ndị ọzọ, Middle East na Africa (gụnyere n'Isi nke 9 na Isi 13) , Saudi Arabia, UAE, Egypt, Nigeria, South Africa, mba ndị ọzọ, South America (kpuchie n'Isi nke 10 na Isi nke 13), Brazil, Argentina, Colombia, Chile na mba ndị ọzọ, tụnyere, na-eduga mba na ohere;Nyocha ụdị ahịa mpaghara, nyocha nke usoro ọkọnọ
Isi nke 10, site n'aka ndị ọkachamara ụlọ ọrụ na ndị na-eme mkpebi atụmatụ iji chọpụta isi ihe na-eme mkpebi;
Isi nke 11 na 12, ngwa ngwa ngwa ngwa Covid-19 antigen test kit market analysis, ihe na-anya ụgbọ ala, ihe ịma aka omume ndị ahịa, ọwa ahịa
Isi nke 15 na-ekwu maka ọwa ahịa ahịa ngwa ngwa Covid-19 antigen test kit ahịa, ndị nkesa, nsonaazụ nyocha na nkwubi okwu, ngwa mgbakwunye na isi mmalite data.
Daalụ maka ịgụ akụkọ a;ị nwekwara ike nweta akụkụ nke amamihe nke isi ma ọ bụ ụdị mkpesa mpaghara, dị ka North America, Europe, ma ọ bụ Asia
Ọnụ ahịa nchekwa nchekwa efu: N'ihe gbasara ego ha nwetara, ahịa nchekwa efu efu zuru ụwa ọnụ ga-abụ ijeri US $ 15.61 na 2020 ma na-atụ anya iru 94.35 ijeri US dollar site na 2027. Ọnụego uto kwa afọ nke njikwa azụmahịa dijitalụ bụ 19.71%.Site na 2020 ruo 2027.
Ahịa ahịa mgbanwe mgbanwe dijitalụ: Ndụmọdụ mgbanwe dijitalụ bụ ọrụ nwere ike inyere ụlọ ọrụ aka imepụta atụmatụ mgbanwe dijitalụ wee mejuputa atumatu iji kwalite arụmọrụ azụmaahịa site na teknụzụ dijitalụ.
Industrylọ ọrụ ụgbọ ala na-epupụta efu: Ọnụego uto kwa afọ nke ụlọ ọrụ ụgbọ ala efu na-atụ anya ka ọ gafere 19.2% n'etiti 2021 na 2027.
Thermoset composites ahịa ahịa: N'ihe banyere ego ha nwetara, ahịa ahịa thermoset composites zuru ụwa ọnụ bụ ijeri US $ 24.08 na 2019, a na-atụkwa anya iru ijeri $ 31.7 na 2026, yana mmụba kwa afọ nke 5.00% site na 2020 ruo 2026 .
Uto nke ahịa ịdị ọcha aka ejikọtara: N'ihe gbasara ego ha nwetara, ihe gbasara ụwa niile maka ọnụ ọgụgụ ahịa ịdị ọcha aka ejikọtara bụ $ 354.44 nde na 2019 ma na-atụ anya iru $ 539.9 nde na 2026, yana mmụba na-abawanye kwa afọ nke 6.55. % site na 2020 ruo 2026.
Echiche ahịa animation: A na-ere ahịa animation na $ 24.23 ijeri na 2020 ma na-atụ anya iru $ 43.73 ijeri site na 2027, yana mmụba kwa afọ nke 8.8% n'oge amụma.
Oge nzipu: Jun-18-2021